Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-52.20	27.63	57.81
Graham Fair Price	42.93	23.40	16.37
PEG	-82.47	0.09	-0.50
Price/Book	-17.07	4.19	5.05
Price/Cash Flow	57.71	489.04	-310.09
Prices/Earnings	-58.54	9.16	22.09
Price/Sales	-58.54	8.57	20.67
Price/FCF	57.71	489.04	-310.09
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-19.75	0.26	0.33
Operating Margin	1.36	0.26	0.26
ROA	100.00	0.06	0.03
ROE	0.06	0.11	100.00
ROIC	0.04	0.09	107.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.01	inf
Dividends QOQ	-1.00	0.01	-98.93
EBIT QOQ	-0.49	1.03	109.49
EPS QOQ	-0.44	1.04	136.47
FCF QOQ	-1.07	1.53	42.09
Revenue QOQ	-0.52	1.00	90.76
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.74	11.74	-54.38
Days Sales Outstanding (DSO)	88.71	52.09	-41.28
Inventory Turnover	3.50	7.66	119.20
Debt/Capitalization	0.24	0.22	-8.34
Quick Ratio	0.99	1.08	8.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	14.43	14.59	1.07
Cash	3.60	3.64	1.07
Capex	-0.40	-0.34	15.04
Free Cash Flow	-0.24	0.12	-46.86
Revenue	3.53	7.13	102.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.22	1.22	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.54	1.45	-42.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating